SCHEMBL6065220

SCHEMBL6065220

COC(=O)/C(Cl)=C/c1ccc(N(C)C)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.52
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
HSD17B3 P37058 1/20 0.46
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 4/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 3/20 0.45
LMNA P02545 2/20 0.45
JAK2 O60674 1/20 0.45
MITF O75030 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13172008 0.83 APP (0.63) APPHDAC3HDAC4HDAC1HDAC7
SCHEMBL701808 0.81 HDAC3 (0.54) APPHDAC3HDAC4HDAC1HDAC7
SCHEMBL701807 0.81 HDAC3 (0.54) APPHDAC3HDAC4HDAC1HDAC7
SCHEMBL6064517 0.79 ALDH1A1 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10625694 0.79 RAB9A (0.53) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL5707178 0.79 RAB9A (0.53) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL9486859 0.79 RAB9A (0.53) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL24027069 0.79 APP (0.51) APPHDAC3HDAC4HDAC1HDAC7
SCHEMBL28367287 0.79 APP (0.58) APPHDAC3HDAC4HDAC1HDAC7
SCHEMBL21758695 0.78 APP (0.50) APPHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084281-B2 Synthesis of dihalohydrins and tri- and tetra-substituted olefins BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2006-08-01 US disclosed
US-20040143125-A1 Synthesis of dihalohydrins and tri- and tetra-substituted olefins BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040143125-A1 Synthesis of dihalohydrins and tri- and tetra-substituted olefins TALDO1, HDHD5, TKT APP 4511/4885HDAC3 2151/4885HDAC4 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.